| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.884270 |
| 003 | CaOODSP |
| 005 | 20221107170823 |
| 006 | m o d f |
| 007 | cr ||||||||||| |
| 008 | 200204t20202020oncd ob f000 0 eng d |
| 020 | |a9780660339382 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aH14-344/2020E-PDF |
| 100 | 1 |aLeigh-Bennett, Richard, |eauthor. |
| 245 | 10|aAssessment of Health Canada's communications to external stakeholders on marketed health products : |bqualitative research : final report / |csubmitted by: Richard Leigh-Bennett ; prepared for: Health Canada. |
| 246 | 17|aMarketed health products communications research report |
| 264 | 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c2020. |
| 264 | 4|c©2020 |
| 300 | |a1 online resource (42 pages) : |bgraphs + |e1 executive summary (6 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aTitle from cover. |
| 500 | |a"February 19, 2020." |
| 500 | |aIssued also in HTML format. |
| 500 | |a"Supplier name: Pollara Strategic Insights." |
| 500 | |a"Contract Number: HT372-184553/001/CY." |
| 500 | |a"POR Registration number: 136-18." |
| 500 | |a"Health Canada POR Number: 18-25." |
| 500 | |aIssued also in French under title: Évaluation des communications de Santé Canada aux intervenants externes à propos des produits de santé commercialisés : recherche qualitative : rapport final. |
| 504 | |aIncludes references. |
| 520 | |a"Health product safety in Canada is a shared responsibility. Many different organizations and individuals, including Health Canada, health care professionals, manufacturers, consumers and others, have a role to play in the effective and timely communication of health product safety information. As part of its role, Health Canada develops a wide range of products designed to communicate externally to key stakeholders (including the public) on issues related to health product safety, including, but not limited to: guidance documents; risk communications; health product safety information; and, communications around transparency"--Background and objectives, page 8. |
| 650 | 0|aHealth products|xGovernment policy|zCanada|xPublic opinion. |
| 650 | 0|aHealth risk communication|xGovernment policy|zCanada|xPublic opinion. |
| 650 | 0|aPublic opinion|zCanada. |
| 710 | 1 |aCanada. |bHealth Canada. |
| 710 | 2 |aPollara Strategic Insights. |
| 775 | 08|tÉvaluation des communications de Santé Canada aux intervenants externes à propos des produits de santé commercialisés : |w(CaOODSP)9.884271 |
| 856 | 40|qPDF|s1,021 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H14-344-2020-eng.pdf|zFinal report |
| 856 | 40|qPDF|s487 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H14-344-2020-1-eng.pdf|zExecutive summary |
| 856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2020/136-18-e/mhpd-e.html|zFinal report |
| 856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2020/136-18-e/summary/summary.html|zExecutive summary |